Loading
Latest filing published 26 May 2026 for 넥스트바이오메디컬.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by 한명식 on record concern 넥스트바이오메디컬, in the capacity of board member. We count 2 filings; the first trade dates from 1 May 2026 and the latest from 26 May 2026.
Every open-market trade on record is a purchase: 2 purchases, and no sale. The amount is not disclosed for 2 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
Most recently, on 26 May 2026, the filings show an open-market purchase in 넥스트바이오메디컬. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.